Non-small Cell Lung Cancer

• ImClone Investigational Site — Los Angeles, California, United States
• ImClone Investigational Site — Santa Monica, California, United States
• ImClone Investigational Site — Newark, Delaware, United States
• ImClone Investigational Site — Orlando, Florida, United States

• ImClone Investigational Site — Bentonville, Arkansas, United States
• ImClone Investigational Site — Tucker, Georgia, United States
• ImClone Investigational Site — Evanston, Illinois, United States
• ImClone Investigational Site — Louisville, Kentucky, United States

• Comprehensive Blood and Cancer Center — Bakersfield, California, United States
• City of Hope — Duarte, California, United States
• University of Southern California — Los Angeles, California, United States
• University of California at Davis — Sacramento, California, United States

• Local Institution — Denver, Colorado, United States
• Local Institution — Rochester, Minnesota, United States
• Local Institution — Toronto, Ontario, Canada

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph — Denver, Colorado, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph — South Bend, Indiana, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph — Baltimore, Maryland, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph — Kalamazoo, Michigan, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Chiba, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Ehime, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Fukuoka, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Gifu, Japan

• Sanofi-Aventis — Milan, Italy

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

• ZNA Middelheim — Antwerp, Belgium
• University Hospital Antwerp — Edegem, Antwerp, Belgium
• St Augustinus Ziekenhuis — Wilrijk, Antwerp, Belgium

Not specified